1) Percentage of women age 15-49 with a live birth or a stillbirth in the 2 years preceding the survey who, during the pregnancy that resulted in the last live birth or stillbirth, received one or more doses of SP/Fansidar.
2) Percentage of women age 15-49 with a live birth or a stillbirth in the 2 years preceding the survey who, during the pregnancy that resulted in the last live birth or stillbirth, received two or more doses of SP/Fansidar.
3) Percentage of women age 15-49 with a live birth or a stillbirth in the 2 years preceding the survey who, during the pregnancy that resulted in the last live birth or stillbirth, received three or more doses of SP/Fansidar.
Coverage:
Population base: Women age 15-49 who had a live birth or a stillbirth in the 2 years preceding the survey (IR file)
Time period: Two years preceding the survey
Numerators:
1) Number of women who had a live birth (m80 = 1) or a stillbirth (m80 = 3) in the 2 years preceding the interview who received one or more doses of SP/Fansidar, in the 2 years preceding the interview (m49a_1 = 1)
2) Number of women who had a live birth (m80 = 1) or a stillbirth (m80 = 3) in the 2 years preceding the interview who received two or more doses of SP/Fansidar, in the 2 years preceding the interview (m49a_1 = 1 & ml1_1 in 2:97)
3) Number of women who had a live birth (m80 = 1) or a stillbirth (m80 = 3) in the 2 years preceding the interview who received three or more doses of SP/Fansidar, in the 2 years preceding the interview (m49a_1 = 1 & ml1_1 in 3:97)
Denominator: Number of women who had a live birth (m80 = 1) or a stillbirth (m80 = 3) in the 2 years preceding the interview (b19_01 < 24)
Variables: IR file.
|
b19_01 |
Current age of child in months |
|
m80 |
Pregnancy outcome for this section |
|
m49a_1 |
During pregnancy took: SP/Fansidar for malaria |
|
ml1_1 |
Number of times took Fansidar during pregnancy |
|
v005 |
Women’s individual sample weight |
Numerator divided by denominator, multiplied by 100.
“Don’t know” and missing values for receiving any SP/Fansidar, and numbers of doses of SP/Fansidar received are treated as “no” responses in calculating the indicators.
This indicator has recently changed to remove the specification that at least one of the SP doses was received during an ANC visit (ml2_1 = 1). The source of the SP doses is still of interest and the data are collected in the survey (ml2_1). In DHS-8, these indicators are shown separate for live births (m80 = 1), stillbirths (m80 = 3), and combined live births and stillbirths.
Chikwasha, V., I. Phiri, P. Chimberengwa, D. Bangure, and S. Rusakaniko. 2014. Predictors of IPTp uptake among pregnant women in the 2010–2011 Zimbabwe demographic and health survey. No. 112. DHS working papers. https://dhsprogram.com/publications/publication-WP112-Working-Papers.cfm
Florey, L. 2013. Preventing malaria during pregnancy in sub-Saharan Africa: Determinants of effective IPTp delivery. DHS Analytical Studies No. 39. Calverton, Maryland, USA: ICF International.
https://dhsprogram.com/publications/publication-as39-analytical-studies.cfm
DHS-8 Tabulation plan: Table 12.9
API Indicator IDs:
ML_IPTP_W_SPF, ML_IPTP_W_2SP, ML_IPTP_W_3SP, ML_IPTP_W_SPA, ML_IPTP_W_2SA, ML_IPTP_W_3SA
Household Survey Indicators for Malaria Control Indicator 8: Proportion of women who received three or more doses of IPTp for malaria during their last pregnancy
WHO 100 Core Health Indicators: Intermittent preventive treatment for malaria during pregnancy (IPTp)
MICS6 Indicator TC.25: Intermittent preventive treatment for malaria during pregnancy